35 Results for 'hector deluca'
PAGE 2 OF 2
Technology
Method Of Treating Multiple Sclerosis
A method and computer program product for suppressing the symptoms of multiple sclerosis (MS) by irradiating a subject exhibiting the symptoms with a pre-determined dose of UV-containing light from a ...
Learn More
Learn More
Hector DeLuca, Bryan Becklund | P100177US03
Technology
2alpha-methyl And 2beta- Methyl Analogs Of 19,26,27-trinor-(20s)-1alpha-hydroxyvitamin D3 And Their
This invention discloses 2α-methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and pharmaceutical uses therefor. These compounds exhibit pronounced activity in arresting the...
Learn More
Learn More
Hector DeLuca, Pawel Grzywacz, Lori Plum, Margaret Clagett-Dame | P09213US
Technology
2-methylene-19,26,27-trinor-(20s)-1alpha-hydroxyvitamin D3 And Its Uses
This invention discloses 2-methylene-19,26,27-trinor-(20S)-vitamin D analogs, and specifically 2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and pharmaceutical uses therefor. This compound e...
Learn More
Learn More
Hector DeLuca, Pawel Grzywacz, Lori Plum, Margaret Clagett-Dame | P09212US
Technology
17,20(e)-dehydro Vitamin D Analogs And Their Uses
This invention discloses 17,20(E)-dehydro vitamin D analogs, and specifically 17(E)-1α,25-dihydroxy-17(20)-dehydro-2-methylene-19-nor-vitamin D3 and pharmaceutical uses therefor. This compound exhibi...
Learn More
Learn More
Hector DeLuca, Margaret Clagett-Dame, Lori Plum, Bulli Padmaja Tadi | P09211US
Technology
17,20(z)-dehydro Vitamin D Analogs And Their Uses
This invention discloses 17,20(Z)-dehydro vitamin D analogs, and specifically 17(Z)-1α,25-dihydroxy-17(20)-dehydro-2-methylene-19-nor-vitamin D3 and pharmaceutical uses therefor. This compound exhibi...
Learn More
Learn More
Hector DeLuca, Margaret Clagett-Dame, Lori Plum, Bulli Padmaja Tadi | P09210US
Technology
(20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol And Its Uses
This invention discloses (20S)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation o...
Learn More
Learn More
Hector DeLuca, Lori Plum, Margaret Clagett-Dame | P07497US
Technology
(20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol And Its Uses
This invention discloses (20S)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation o...
Learn More
Learn More
Hector DeLuca, Lori Plum, Margaret Clagett-Dame | P07496US
Technology
1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D Compounds With A 1,1-dimethylpropyl Side C
This invention discloses 1α-hydroxy-2-(3′-hydroxypropylidene)-19-nor-vitamin D compounds with a 1,1-dimethylpropyl side chain, and pharmaceutical uses therefor. These compounds exhibit pronounced a...
Learn More
Learn More
Hector DeLuca, Rafal Sicinski, Lori Plum, Agnieszka Glebocka, Margaret Clagett-Dame | P06381US
Technology
Synthesis And Biological Activity Of 2-Methylene Analogs Of Calcitriol And Related Compounds
Disclosed are 2-methylene analogs of vitamin D3 and related compounds, their biological activities, and various pharmaceutical uses for these analogs. Particularly disclosed are 1α-hydroxy-2-methylen...
Learn More
Learn More
Hector DeLuca, Lori Plum, Rafal Sicinski, Izabela Sibilska-Kaminski | P160027US02
Technology
1-Alpha, 25-Dihydroxy-24,24-Difluoro-19-Nor-Vitamin D3 Analogs And Their Pharmaceutical Uses
Disclosed are 1α,25-dihydroxy-24,24-difluoro-2-methylene-19-nor-vitamin D analogs and their pharmaceutical uses. These new vitamin D analogs are 19-nor-vitamin D analogs having two fluorine atom subs...
Learn More
Learn More
Hector DeLuca, Lori Plum, Agnieszka Flores, Hazel Holden, James Thoden | P150305US02